U.S. Circulating Tumor Cells Market (2024 - 2030) Size, Share & Trends Analysis Report By Application (Clinical/Liquid Biopsy, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, And Segment Forecasts

Market Segmentation

U.S. Circulating Tumor Cells Technology Outlook (Revenue in USD Million, 2018 - 2030)
- CTC detection & enrichment methods
  - Immunocapture (label-based)
    - Positive selection
    - Negative selection
  - Size-based separation (label-free)
    - Membrane-based
    - Microfluidic-based
  - Density-based separation (label-free)
  - Combined methods
- CTC Direct Detection Methods
  - SERS
  - Microscopy
  - Others
- CTC Analysis
U.S. Circulating Tumor Cells Application Outlook (Revenue in USD Million, 2018 - 2030)
- Clinical/ Liquid Biopsy
  - Risk Assessment
  - Screening and Monitoring
- Research
  - Cancer stem cell & tumorogenesis research
  - Drug/therapy development
U.S. Circulating Tumor Cells Product Outlook (Revenue in USD Million; 2018 - 2030)
- Kits & Reagents
- Blood Collection Tubes
- Devices or Systems
U.S. Circulating Tumor Cells Specimen Outlook (Revenue in USD Million; 2018 - 2030)
- Blood
- Bone Marrow
- Other Body Fluids

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments